• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Transl Med . Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Sci Transl Med


. 2024 Jul 3;16(754):eadk3295.
doi: 10.1126/scitranslmed.adk3295. Epub 2024 Jul 3. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection

Michael J Peluso[SUP] 1 [/SUP], Dylan Ryder[SUP] 1 2 [/SUP], Robert R Flavell[SUP] 3 [/SUP], Yingbing Wang[SUP] 3 [/SUP], Jelena Levi[SUP] 4 [/SUP], Brian H LaFranchi[SUP] 2 [/SUP], Tyler-Marie Deveau[SUP] 2 [/SUP], Amanda M Buck[SUP] 2 [/SUP], Sadie E Munter[SUP] 1 2 [/SUP], Kofi A Asare[SUP] 1 2 [/SUP], Maya Aslam[SUP] 3 [/SUP], Walter Koch[SUP] 3 [/SUP], Gyula Szabo[SUP] 5 [/SUP], Rebecca Hoh[SUP] 1 [/SUP], Monika Deswal[SUP] 1 [/SUP], Antonio E Rodriguez[SUP] 1 [/SUP], Melissa Buitrago[SUP] 1 [/SUP], Viva Tai[SUP] 1 [/SUP], Uttam Shrestha[SUP] 3 [/SUP], Scott Lu[SUP] 6 [/SUP], Sarah A Goldberg[SUP] 6 [/SUP], Thomas Dalhuisen[SUP] 6 [/SUP], Joshua J Vasquez[SUP] 2 [/SUP], Matthew S Durstenfeld[SUP] 7 [/SUP], Priscilla Y Hsue[SUP] 7 [/SUP], J Daniel Kelly[SUP] 6 [/SUP], Nitasha Kumar[SUP] 2 [/SUP], Jeffrey N Martin[SUP] 6 [/SUP], Aruna Gambhir[SUP] 4 [/SUP], Ma Somsouk[SUP] 8 [/SUP], Youngho Seo[SUP] 3 [/SUP], Steven G Deeks[SUP] 1 [/SUP], Zoltan G Laszik[SUP] 5 [/SUP], Henry F VanBrocklin[SUP] 3 [/SUP], Timothy J Henrich[SUP] 2 [/SUP]



Affiliations
Abstract

The mechanisms of postacute medical conditions and unexplained symptoms after SARS-CoV-2 infection [Long Covid (LC)] are incompletely understood. There is growing evidence that viral persistence, immune dysregulation, and T cell dysfunction may play major roles. We performed whole-body positron emission tomography imaging in a well-characterized cohort of 24 participants at time points ranging from 27 to 910 days after acute SARS-CoV-2 infection using the radiopharmaceutical agent [[SUP]18[/SUP]F]F-AraG, a selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the postacute COVID-19 group, which included those with and without continuing symptoms, was higher compared with prepandemic controls in many regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. T cell activation in the spinal cord and gut wall was associated with the presence of LC symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms specifically. Increased T cell activation in these tissues was also observed in many individuals without LC. Given the high [[SUP]18[/SUP]F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization of SARS-CoV-2 RNA and immunohistochemical studies in a subset of five participants with LC symptoms. We identified intracellular SARS-CoV-2 single-stranded spike protein-encoding RNA in rectosigmoid lamina propria tissue in all five participants and double-stranded spike protein-encoding RNA in three participants up to 676 days after initial COVID-19, suggesting that tissue viral persistence could be associated with long-term immunologic perturbations.


 
Back
Top Bottom